Close

Valeant (VRX) Division Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion

January 12, 2018 7:02 AM EST Send to a Friend
Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) ("Valeant") , today announced that the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login